Back to top
Celvestrant 250 mg PFS
Celvestrant 250 mg PFS

Celvestrant 250 mg PFS

Celvestrant 250 mg PFS Specification

  • Salt Composition
  • Fulvestrant
  • Origin of Medicine
  • Synthetic
  • Pacakaging (Quantity Per Box)
  • 1 Pre-filled Syringe
  • Drug Type
  • Anticancer Drug
  • Ingredients
  • Fulvestrant 250 mg
  • Physical Form
  • Pre-filled Syringe (PFS)
  • Function
  • Hormonal Therapy for Breast Cancer
  • Recommended For
  • Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer
  • Dosage
  • 250 mg administered intramuscularly
  • Dosage Guidelines
  • Administer 250 mg every two weeks for the first three doses followed by 250 mg once monthly thereafter
  • Suitable For
  • Adults specifically postmenopausal women
  • Quantity
  • 1 syringe per box
  • Storage Instructions
  • Store refrigerated at 2C to 8C (36F to 46F) do not freeze and protect from light
 
 

About Celvestrant 250 mg PFS



Celvestrant 250 mg PFS is a potent Anticancer Drug containing 250 mg of Fulvestrant in each Pre-filled Syringe (PFS). It is designed for Hormonal Therapy in postmenopausal women with Hormone Receptor-Positive Advanced Breast Cancer. This synthetic medication is administered intramuscularly with a dosage of 250 mg every two weeks for the first three doses followed by 250 mg monthly. Each box contains 1 syringe and should be stored refrigerated at 2C to 8C, protected from light.

FAQs of Celvestrant 250 mg PFS:


Q: What is Celvestrant 250 mg PFS used for?

A: Celvestrant 250 mg PFS is used for Hormonal Therapy in postmenopausal women with Hormone Receptor-Positive Advanced Breast Cancer.

Q: How should Celvestrant 250 mg PFS be stored?

A: Celvestrant 250 mg PFS should be stored refrigerated at 2C to 8C, and protected from light.

Q: What is the dosage recommendation for Celvestrant 250 mg PFS?

A: The recommended dosage is 250 mg administered intramuscularly every two weeks for the first three doses, followed by 250 mg monthly thereafter.

Q: Is Celvestrant 250 mg PFS suitable for all adults?

A: Celvestrant 250 mg PFS is specifically suitable for postmenopausal women.

Q: What is the salt composition of Celvestrant 250 mg PFS?

A: The salt composition of Celvestrant 250 mg PFS is Fulvestrant.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti-Cancer Category

Procabazi Injection

Procabazi Injection

Quantity : 1 vial (60 mg/1.5 ml)

Ingredients : Cabazitaxel

Recommended For : Adult males with advanced prostate cancer

Storage Instructions : Store at 2C to 8C. Keep away from light and do not freeze.

Pacakaging (Quantity Per Box) : 1 vial per box

Dosage : As prescribed by the oncologist

Capsy 500 mg Tablet

Capsy 500 mg Tablet

Quantity : 10 tablets per strip

Ingredients : Capsuleform Salt Mixture (e.g. Paracetamol Specific Active Ingredients etc.)

Recommended For : Adults and elderly

Storage Instructions : Store in a cool dry place away from sunlight and moisture.

Pacakaging (Quantity Per Box) : 10 strips per box

Dosage : 500 mg per tablet

Okeron 0.05 mg Injection

Okeron 0.05 mg Injection

Quantity : Typically provided as singleuse vials or ampoules

Ingredients : Active ingredient not provided typically includes Octreotide or similar compound

Recommended For : Patients with carcinoid tumors acromegaly or other conditions as prescribed by medical professionals

Storage Instructions : Store in a refrigerator at 28C (3646F); protect from light

Pacakaging (Quantity Per Box) : Varies commonly 1 to 10 vials per box

Dosage : 0.05 mg per dose

Cytax 300 mg Injection

Cytax 300 mg Injection

Quantity : Single vial

Ingredients : Paclitaxel

Recommended For : Patients undergoing cancer treatment as prescribed by an oncologist

Storage Instructions : Store in a cool dry place away from direct sunlight and moisture at 2C to 8C

Pacakaging (Quantity Per Box) : 1 vial per box

Dosage : 300 mg